-
Patient Factors Influencing Intraocular Penetration of Brimonidine-Related Eye Drops in Adults: A Post Hoc Pooled Analysis
Eriko Kunikane1, Yusuke Orii2, Akiko Inoue1, Masaru Inatani2
1 Senju Pharmaceutical Co., Ltd.
2 University of Fukui
Ophthalmol Ther (2023). https://doi.org/10.1007/s40123-023-00794-x
-
New Candidate Preservative in Ophthalmic Solution Instead of Benzalkonium Chloride: 1,3-Didecyl-2-methyl Imidazolium Chloride
Takuya Iwasaki, Ryosuke Uchiyama, and Kazuto Nosaka
Chemical and Pharmaceutical Bulletin 71(7) 552–557, 2023
-
Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study
Yusuke Orii1, Eriko Kunikane2, Yutaka Yamada1, Masakazu Morioka1, Kentaro Iwasaki1, Shogo Arimura1,Akemi Mizuno2 and Masaru Inatani1
1 Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Fukui 910-1193, Japan
2 Senju Pharmaceutical Co., Ltd., Osaka 541-0048, Japan
J. Clin. Med. 2023, 12, 4175. https://doi.org/10.3390/jcm12134175
-
A survey of on the use of genotoxicity and carcinogenicity testing packages for ophthalmic drug development
Haruna Tahara,Yu Haranosono
Fundamental Toxicological Sciences. 2023; 10(3): 105-112.
-
Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan
Yasuo Yanagi1, Kanji Takahashi2, Tomohiro Iida3, Fumi Gomi4, Junko Morii5, Eriko Kunikane6, Taiji Sakamoto7
1 Department of Ophthalmology and Microtechnology, Yokohama City University, Kanagawa, Japan.
2 Department of Ophthalmology, Kansai Medical University, Osaka, Japan.
3 Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan.
4 Department of Ophthalmology, Hyogo Medical University, Hyogo, Japan.
5 IQVIA Solutions Japan, K.K., Tokyo, Japan.
6 Senju Pharmaceutical Co., Ltd., Osaka, Japan.
7 Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Ophthalmology and Therapy. 2023. doi:10.1007/s40123-023-00715-y.
-
点眼剤の製剤設計とそのポイント
山口正純
製剤の達人による製剤技術の伝承 製剤設計・製造技術 BASIC&FRONTIER, 429-442
-
薬物ナノ結晶製剤の眼内動態評価と眼疾患治療への応用性
増田 柊也1、長井 紀章2
1近畿大学薬学部(千寿製薬株式会社)
2近畿大学薬学部
(株)技術情報協会発刊書籍「新規モダリティ医薬品のための新しいDDS技術と製剤化」
-
Effects of Astaxanthin, Lutein, and Zeaxanthin on Eye–Hand Coordination and Smooth-Pursuit Eye Movement after Visual Display Terminal Operation in Healthy Subjects: A Randomized, Double-Blind Placebo-Controlled Intergroup Trial
Keisuke Yoshida 1* , Osamu Sakai 1, Tomoo Honda 1, Tomio Kikuya 1, Ryuji Takeda 2 , Akiyoshi Sawabe 3 , Masamaru Inaba 4 and Chieko Koike 5,6*
1 Senju Pharmaceutical, Co., Ltd., Osaka 541-0048, Japan
2 Department of Nutritional Sciences for Well-Being, Faculty of Health Sciences for Welfare, Kansai University of Welfare Sciences, Osaka 582-0026, Japan
3 Department of Applied Biological Chemistry, Faculty of Agriculture, Kindai University, Nara 631-8505, Japan
4 Inaba Eye Clinic, Osaka 530-0001, Japan
5 College of Pharmaceutical Sciences, Ritsumeikan University, Shiga 525-8577, Japan
6 Center for Systems Vision Science, Research Organization of Science and Technology, Ritsumeikan University, Shiga 525-8577, Japan
* Correspondence: k-yoshida@senju.co.jp (K.Y.); koike@fc.ritsumei.ac.jp (C.K.); Tel.: +81-6-6201-2512 (K.Y.)
Nutrients 2023, 15, 1459.
-
GCL loss in BRAO
Thomas R. Shearer 1, Peter N. Steinkamp 2, Maria Parker 2, Mitsuyoshi Azuma 1,3
1 Department of Integrative Biomedical & Diagnostic Sciences, Oregon Health & Science University, Portland, Oregon, USA.
2 Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon, USA.
3 Senju Laboratory of Ocular Sciences, Portland, Oregon, USA.
PLoS One. 2023; 18:e0279920
-
Two cases of cartilaginous metaplasia in the sclera of Japanese White rabbits
Kotaro Yamada, Yoshinori Yamagiwa, Miki Masatsugu, and Yu Haranosono
Journal of Toxicologic Pathology. 2023; 36: 45–48.